IP Library Granted Patent US 10,011,569
Granted Patent B2
US 10,011,569 · App. 15/483,331 · Granted Jul 3, 2018

Process for synthesizing oxidized lactam compounds

Inventors: Julius F. Remenar (Framingham, MA); Laura Cook Blumberg (Lincoln, MA); Tarek A. Zeidan (Lexington, MA)
Assignee: Alkermes Pharma Ireland Limited
C07D215/227C07D215/22C07D401/12C07D401/14C07F9/65583C07F9/650952
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,011,569
App. No.
15/483,331
Granted
Jul 3, 2018
Kind
B2
Abstract

The invention provides a method for the synthesis of dehydrogenated lactam drugs of Formula I:

Claims (162)

1. A method for preparing a compound of Formula V, comprising the step of reacting a compound of Formula VA:

with a compound of Formula II:

in the presence of an acid, wherein

Each R A , R B , R C , and R D is independently selected from hydrogen, halogen, —CN, NH 2 , NR 100 R 101 , SR 100 , OR 100 , aliphatic, substituted aliphatic, aryl and substituted aryl; wherein R 100 and R 101 , are independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

X is —S— or —O—;

X 2 is selected from CH and N;

R 1 , is selected from H, —C(R J )(R K )—OR 20 , —C(R J )(R K )—OC(O)OR 20 , —C(R J )(R K )—OC(O)R 20 , —C(R J )(R K )—OC(O)NR 20 R 21 , —(C(R J )(R K ))—OPO 3 MY, —(C(R J )(R K ))—OP(O)(OR 20 )(OR 21 ), —[C(R J )(R K )O] z —R 20 , —[C(R J )(R K )O] z —C(O)OR 20 , —[C(R J )(R K )O] z —C(O)R 20 , —[C(R J )(R K )O] z —C(O)NR 20 R 21 , —[C(R J )(R K )O] z —OPO 3 MY, —[C(R J )(R K )O] z —P(O) 2 (OR 20 )M and —[C(R J )(R K )O] z —P(O)(OR 20 )(OR 21 );

wherein each R J and R K is independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

each R 20 and R 21 is independently selected from hydrogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

Y and M are the same or different and each is a monovalent cation; or M and Y together is a divalent cation; and

z is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;

R 2 is hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

n is selected from 0, 1, 2 or 3;

q is 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9;

R 6 is independently absent, hydrogen, halogen, aliphatic, substituted aliphatic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl or substituted heterocyclyl;

R 7 and R 8 are independently selected from absent, hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; and

wherein said compound of Formula VA contain a primary, secondary or tertiary amine having a pKa of about 6 to about 45.

2. The method according to claim 1 , wherein R 6 is selected from:

wherein R 100 R 101 , and R 103 are independently selected from hydrogen, halogen, optionally substituted C 1 -C 8 alkyl, optionally substituted C 2 -C 8 alkenyl, optionally substituted C 2 -C 8 alkynyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 8 alkoxy, optionally substituted C 1 -C 8 alkylamino and optionally substituted C 1 -C 8 aryl.

3. The method according to claim 2 , wherein R 6 is selected from

4. A method according to claim 1 , wherein R 1 is selected from Tables 1-4.

TABLE 1

TABLE 2

TABLE 3

TABLE 4

5. The method according to claim 1 , wherein said compound of Formula II is selected from 2,3-dichloro-5,6-dicyano-1,4-benzoquinone or para-benzoquinone.

6. The method according to claim 1 , wherein said acid is selected from trifluroacetic acid, p-toluenesulfonic acid, trifluoromethanesulfonic acid, chlorosulfonic acid, dichloroacetic acid, trichloroacetic acid, acetic acid, propionic acid, sulfuric acid, phosphoric acid, nitric acid, camphorsulfonic acid, hydrochloric acid, oxalic acid, formic acid, propanoic acid, butanoic acid, pentanoic acid, benzoic acid, pyruvic acid, malonic acid, succinic acid, glutaric acid, fumaric acid, citric acid, ascorbic acid, tartaric acid, maleic acid, hydrobromic acid, and mixtures thereof.

7. The method according to claim 6 , wherein said acid is trifluroacetic acid.

8. The method according to claim 1 , wherein the reaction is conducted in a solvent selected from tetrahydrofuran, tert-butylmethylether, dimethoxy-ethane, dioxane, benzene, toluene, xylene, dimethylformamide, acetone, acetonitrile, chloroform, dichloromethane, 1,2-dichloroethane, ethyl acetate, n-propyl acetate, isopropyl acetate, methyl-t-butyl ether, methyl butyl ketone and combinations thereof.

9. The method according to claim 1 , wherein said pKa range of primary, secondary or tertiary amine is between about 6 to about 30.

10. The method according to claim 1 , wherein said compound of Formula VA is selected from Table A:

TABLE A

No

Structure

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

11. A method for preparing a compound having the structure

comprising the step of reacting a compound having the structure

with a compound of Formula II:

wherein

Each R A , R B , R C , and R D is independently selected from hydrogen, halogen, —CN, NH 2, NR 100 R 101 , SR 100 , OR 100 , aliphatic, substituted aliphatic, aryl and substituted aryl; wherein R 100 and R 101 , are independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl;

in the presence of an acid.

12. The method according to claim 11 , wherein said compound of Formula II is selected from 2,3-dichloro-5,6-dicyano-1,4-benzoquinone or para-benzoquinone.

13. The method according to claim 11 , wherein said acid is selected from trifluroacetic acid, p-toluenesulfonic acid, trifluoromethanesulfonic acid, chlorosulfonic acid, dichloroacetic acid, trichloroacetic acid, acetic acid, propionic acid, sulfuric acid, phosphoric acid, nitric acid, camphorsulfonic acid, hydrochloric acid, oxalic acid, formic acid, propanoic acid, butanoic acid, pentanoic acid, benzoic acid, pyruvic acid, malonic acid, succinic acid, glutaric acid, fumaric acid, citric acid, ascorbic acid, tartaric acid, maleic acid, hydrobromic acid, and mixtures thereof.

14. The method according to claim 13 , wherein said acid is trifluroacetic acid.

15. The method according to claim 11 , wherein the reaction is conducted in a solvent selected from tetrahydrofuran, tert-butylmethylether, dimethoxy-ethane, dioxane, benzene, toluene, xylene, dimethylformamide, acetone, acetonitrile, chloroform, dichloromethane, 1,2-dichloroethane, ethyl acetate, n-propyl acetate, isopropyl acetate, methyl-t-butyl ether, methyl butyl ketone and combinations thereof.

Assignments (3)
SECURITY INTEREST Recorded Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (073213/0302) Recorded Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
SECURITY INTEREST Recorded Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Continuity (5)
Continuation 14808080 · Jul 24, 2015
Continuation 13957694 · Aug 2, 2013
Division 13100515 · May 4, 2011
Provisional Application 61331128 · May 4, 2010
Related Publication 20170267639A1 · Sep 21, 2017